These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 16194364)
1. [The nuclear factor kappa B activation: the key step of cell proliferation in estrogen receptor-negative breast cancer cells]. Wang HJ; Wu ZY; Fan P; Bian JM Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):1014-6. PubMed ID: 16194364 [TBL] [Abstract][Full Text] [Related]
2. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling. Jiang J; Slivova V; Sliva D Int J Oncol; 2006 Sep; 29(3):695-703. PubMed ID: 16865287 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate. Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088 [TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway. Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599 [TBL] [Abstract][Full Text] [Related]
5. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation. Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108 [TBL] [Abstract][Full Text] [Related]
6. Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. Biswas DK; Iglehart JD J Cell Physiol; 2006 Dec; 209(3):645-52. PubMed ID: 17001676 [TBL] [Abstract][Full Text] [Related]
7. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs. Monks NR; Pardee AB J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291 [TBL] [Abstract][Full Text] [Related]
8. TNF-alpha enhances estrogen-induced cell proliferation of estrogen-dependent breast tumor cells through a complex containing nuclear factor-kappa B. Rubio MF; Werbajh S; Cafferata EG; Quaglino A; Coló GP; Nojek IM; Kordon EC; Nahmod VE; Costas MA Oncogene; 2006 Mar; 25(9):1367-77. PubMed ID: 16331275 [TBL] [Abstract][Full Text] [Related]
9. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/P44 MAPK, JNK, Akt and NF-kappa B-dependent pathways. Rivas MA; Carnevale RP; Proietti CJ; Rosemblit C; Beguelin W; Salatino M; Charreau EH; Frahm I; Sapia S; Brouckaert P; Elizalde PV; Schillaci R Exp Cell Res; 2008 Feb; 314(3):509-29. PubMed ID: 18061162 [TBL] [Abstract][Full Text] [Related]
10. Fhit protein inhibits cell growth by attenuating the signaling mediated by nuclear factor-kappaB in colon cancer cell lines. Nakagawa Y; Akao Y Exp Cell Res; 2006 Aug; 312(13):2433-42. PubMed ID: 16733051 [TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells. Biswas DK; Cruz AP; Gansberger E; Pardee AB Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8542-7. PubMed ID: 10900013 [TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogenic and nuclear factor kappa B functions by polyamines and their role in polyamine analog-induced apoptosis of breast cancer cells. Shah N; Thomas TJ; Lewis JS; Klinge CM; Shirahata A; Gelinas C; Thomas T Oncogene; 2001 Mar; 20(14):1715-29. PubMed ID: 11313919 [TBL] [Abstract][Full Text] [Related]
13. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation. Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232 [TBL] [Abstract][Full Text] [Related]
14. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. Yang C; Klein EA; Assoian RK; Kazanietz MG Biochem J; 2008 Feb; 410(1):167-75. PubMed ID: 17941827 [TBL] [Abstract][Full Text] [Related]
15. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224 [TBL] [Abstract][Full Text] [Related]
16. NF-kappaB and estrogen receptor alpha interactions: Differential function in estrogen receptor-negative and -positive hormone-independent breast cancer cells. Gionet N; Jansson D; Mader S; Pratt MA J Cell Biochem; 2009 Jun; 107(3):448-59. PubMed ID: 19350539 [TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor activates nuclear factor-kappaB in human proximal tubule cells. Häussler U; von Wichert G; Schmid RM; Keller F; Schneider G Am J Physiol Renal Physiol; 2005 Oct; 289(4):F808-15. PubMed ID: 15798085 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of polymyxin B on NF-kappaB activation and expression of procollagen I, III in pre-eclamptic umbilical artery smooth muscle cells. Jiang RZ; Chen HP; Xu XY Chin Med J (Engl); 2006 Mar; 119(5):384-90. PubMed ID: 16542581 [TBL] [Abstract][Full Text] [Related]
19. The breast cancer cells response to chronic hypoxia involves the opposite regulation of NF-kB and estrogen receptor signaling. Scherbakov AM; Lobanova YS; Shatskaya VA; Krasil'nikov MA Steroids; 2009 Jun; 74(6):535-42. PubMed ID: 19428442 [TBL] [Abstract][Full Text] [Related]